key: cord-0806965-ocyuqn8i
authors: Bhaskar, L.V.K.S.; Roshan, Bijan; Nasri, Hamid
title: The Fuzzy Connection between SARS-CoV-2 Infection and Loss of Renal Function
date: 2020-06-29
journal: Am J Nephrol
DOI: 10.1159/000508087
sha: 65430fc8dceefe04ac80993d7d2d2d179cf61e60
doc_id: 806965
cord_uid: ocyuqn8i

nan

Dear Editor, We appreciate the highly time-appropriate information presented in the article "Coronavirus Disease 19 Infection Does Not Result in Acute Kidney Injury: An Analysis of 116 Hospitalized Patients from Wuhan, China" by Wang et al. [1] . COVID-19 (coronavirus disease) is a newly emerged pandemic caused by a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As a close relative of other epidemic coronaviruses (SARS and Middle East Respiratory Syndrome), SARS-CoV-2 is highly contagious and exhibits flu-like symptoms with pneumonic illness [1] . Although 85% of patients recover from infection without needing hospitalization, elderly people and people with another condition that compromises the immune system such as hypertension or diabetes appear to develop serious illness [1, 2] . Detection of viral RNA in urine and kidney tissue of SARS-CoV-2-infected patients indicates the kidney as a target of infection [2] . Several of the recent reviews have mentioned kidney manifestations of COVID-19 [3, 4] . While angiotensinconverting enzyme 2 (ACE2) receptors are the functional receptor for the SARS coronavirus, their presentation in the lower respiratory tract, kidney, duodenum, and small intestine might provide possible routes of entry for the SARS-CoV [5] . Studies in a mouse model of SARS-CoV infection demonstrated that ACE2 expression is vital for viral entry and ACE2 overexpression is directly proportional to disease severity [6] . As bradykinin B1 receptor mediates the cross talk between ACE2 and the kinin-kallikrein system in setting the inflammation, selective bradykinin B1 receptor blockers could be used as a promising agent to prevent tissue inflammation during CO-VID-19 infection [7] .

Significant functional impairment of the kidney in COVID-19 patients [8, 9] is well known, and we see that in our patients frequently. Development of acute kidney injury (AKI) is also associated with significant increased mortality during hospital stay [9] . AKI can be a surrogate for multi-organ failure and serves as a negative prognostic factor for survival in COVID-19 patients [10] .

We wonder whether the incidence of AKI by reporting time, and not the total incidence of AKI, was reported in this study by Wang et al. [1] They report that as of February 13, 2020, 7 (6.03%) acute respiratory distress syndrome patients transferred to ICU died of respiratory failure. This is much lower than the overall mortality of more than 52% reported for acute respiratory distress syndrome in COVID-19 patients from Wuhan [10] . We suspect the same methodologic problem underlies the underestimation of AKI in COVID-19 in his study. Therefore, larger studies in this regard are necessary.

Coronavirus disease 19 infection does not result in acute kidney injury: an analysis of 116 hospitalized patients from wuhan, China

The novel coronavirus 2019 epidemic and kidneys

Coronavirus-nephropathy; renal involvement in COVID-19

What the European and American health care systems can learn from China CO-VID-19 epidemic; action planning using purpose designed medical telecommunication, courier services, home-based quarantine, and COVID-19 walk-in centers

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

Mice transgenic for human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection

COVID-19 interactions with angiotensin-converting enzyme 2 (ACE2) and the kinin system; looking at a potential treatment

Kidney disease is associated with in-hospital death of patients with CO-VID-19

Infectious pathways of SARS-CoV-2 in renal tissue

Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China